FDA approves Latuda to treat schizophrenia in adults The U.S.
FDA approves Latuda to treat schizophrenia in adults
The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia.
« FDA, State of Maryland, and Baugher Enterprise warn consumers to | Main | Liz Lovely Issues Voluntary Recall on Products Containing Chocolate Due »